Non-small-cell lung cancer (NSCLC ... begins in the alveoli (the tiny air sacs in the lungs), called adenocarcinoma in situ (AIS), previously known as bronchioloalveolar carcinoma.

I want my family to understand our shared cancer risks, but I sometimes struggle to face the painful reality of the disease ...

Detailed price information for Theralase Technologies Inc (TLT-X) from The Globe and Mail including charting and trades.

Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on ...

The objective of this study was to assess whether adding CAN-2409 in combination with the prodrug valacyclovir to standard of care radiation therapy could improve the proportion of patients achieving ...

Pfizer Inc. (NYSE: PFE) today announced statistically significant and clinically meaningful survival results from the Phase 3 ...

More and more thoracic CT scans are being performed worldwide in order to detect lung diseases such as bronchial carcinoma ...

A 14-gene molecular assay could help predict which patients with early-stage non-small cell lung cancer will benefit from ...

Mumbai: Johnson & Johnson MedTech announced its collaboration with Qure.ai as a strategic partner with Johnson & Johnson Private Limited, to enhance early detection of lung cancer in India to ...